Insider · CIK 0001929422
Brendan Hannah
Files at QNCX (Quince Therapeutics, Inc.). First filing -, latest -.
Brendan Hannah files SEC Form 4 as COO at QNCX (Quince Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Brendan Hannah has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 8 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 23, 2026 | QNCX Quince Therapeutics, Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | -365,000 | $0.00 | $0 | 365,000 | Jan 23, 2026 |
| Dec 5, 2025 | QNCX Quince Therapeutics, Inc. | MOption exercise Common Shares | +2,271 | $0.55 | $1,249 | 336,547 | Dec 8, 2025 |
| Dec 5, 2025 | QNCX Quince Therapeutics, Inc. | MOption exercise Common Shares | +25,280 | $0.94 | $24k | 361,827 | Dec 8, 2025 |
| Dec 5, 2025 | QNCX Quince Therapeutics, Inc. | MOption exercise Employee Stock Option (Right to Buy)derivative | -2,271 | $0.00 | $0 | 45,168 | Dec 8, 2025 |
| Dec 5, 2025 | QNCX Quince Therapeutics, Inc. | MOption exercise Employee Stock Option (Right to Buy)derivative | -25,280 | $0.00 | $0 | 199,720 | Dec 8, 2025 |
| Jun 18, 2025 | QNCX Quince Therapeutics, Inc. | AGrant or award Common Shares | +37,736 | $1.20 | $45k | 334,276 | Jun 23, 2025 |
| Jun 18, 2025 | QNCX Quince Therapeutics, Inc. | AGrant or award Warrantsderivative | +37,736 | $0.13 | $4,717 | 37,736 | Jun 23, 2025 |
| Jan 28, 2025 | QNCX Quince Therapeutics, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +450,000 | $0.00 | $0 | 450,000 | Feb 11, 2025 |
Questions about Brendan Hannah
Answered from the filings on this page, as of the latest one.
Is Brendan Hannah buying or selling?
Brendan Hannah has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Brendan Hannah's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Brendan Hannah has 0.
Where does Brendan Hannah file Form 4?
Brendan Hannah has filed Form 4 at QNCX (Quince Therapeutics, Inc.) as CBO, COO & CCO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.